课题基金 / 基金详情

甲基化酶NSUN2介导的TGFB1 mRNA-m5C修饰激活TGF-β信号通路促进肾癌转移的机制研究

批准号:
82103587
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
张李振
依托单位:
学科分类:
肿瘤复发与转移
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
张李振

项目摘要

结项摘要

相似基金

相关文献

中文摘要
肿瘤转移是癌症致死的主要原因。mRNA m5C修饰调控RNA稳定性和翻译,其在肿瘤转移中的作用及机制尚不明确。我们发现:mRNA m5C水平和m5C相关蛋白NSUN2/YBX1在肾癌组织及其转移灶中上调,其表达与患者预后负相关;敲除NSUN2/YBX1抑制肾癌细胞体外迁移和体内转移;敲除NSUN2降低TGFB1 mRNA的m5C水平及其稳定性;敲除NSUN2/YBX1抑制TGFB1表达和TGF-β信号通路。据此提出假说:NSUN2提高TGFB1 mRNA的m5C水平,在YBX1的介导下增强TGFB1的mRNA稳定性,进而激活TGF-β信号通路以及促进肾癌转移。本项目拟采用基因敲除、转录组和甲基化组测序等方法,结合体内外模型和临床标本,阐明NSUN2/YBX1介导的mRNA m5C修饰紊乱在肾癌转移中的功能及其机制,为m5C通路作为高危肾癌患者术后降低复发转移的辅助治疗靶点提供理论依据。
英文摘要
Metastasis is the foremost cause of cancer-related death. mRNA 5-methylcytosine (m5C) regulates the stability and translation of mRNAs, the roles of which in tumor metastasis and the underlying mechanism remain unknown. We found that the levels of mRNA m5C and NSUN2/YBX1 were upregulated in human renal cell carcinoma (RCC) and metastatic tissues and were inversely correlated with prognosis of RCC. Knockout of NSUN2/YBX1 inhibited in vitro migration and in vivo metastasis of RCC cells. The levels of TGFB1 mRNA m5C and the mRNA stability of TGFB1 were significantly decreased by NSUN2/YBX1 knockout. In addition, Knockout of NSUN2/YBX1 reduced the expression of TGFB1 and repressed the TGF-β signaling pathway. Therefore, we hypothesized that NSUN2 increased the level of TGFB1 mRNA m5C, and then enhanced the YBX1-mediated mRNA stability of TGFB1 to activate the TGF-β signaling pathway, resulting in the promotion of RCC metastasis. Based on these preliminary findings, we will perform biological experiments including gene knockout, RNA-Seq and m5C-Bis-Seq, and combine in vitro and in vivo models as well as clinical samples, to disclose the roles and the underlying mechanism of NSUN2/YBX1 mediated deregulation of mRNA m5C in RCC metastasis. Our results will provide theoretical basis for m5C pathway as a potential target for the treatment of high-risk RCC patients to reduce relapse and metastasis.
减缓或阻断肿瘤转移进展是癌症治疗的关键且难点。RNA m5C修饰调控是基因表达调控网络中的重要环节,细胞中RNA m5C修饰调控异常与肿瘤发生发展密切相关,然而m5C修饰调控分子在肾癌转移中的角色尚不明确。预转移灶的形成在肿瘤远处转移中扮演重要角色,而目前调控预转移灶形成的关键分子仍有待进一步发掘。在本项目研究中,我们发现:1)RNA m5C甲基转移酶NSUN2和长非编码RNA lnc-Ip53在肾癌中异常表达上调,其表达水平均与肾癌患者的预后显著负相关;靶向NSUN2或lnc-Ip53均可削弱肾癌细胞的体内外转移;机制研究显示,NSUN2通过提高lnc-Ip53的RNA m5C水平,在YBX1的介导下增强lnc-Ip53的RNA稳定性,lnc-Ip53进一步结合SMAD2/3并促进其磷酸化修饰,进而激活TGF-β信号通路以及促进肾癌转移。2)系统筛选出影响肺预转移灶形成进而调控肿瘤肺转移的潜在分子IL-1β,并进行了深入研究。Il1b基因敲除或其受体Il1r1靶向病毒均可抑制肺预转移灶形成和肿瘤肺转移;机制研究显示,肺泡巨噬细胞表达分泌IL-1β,其一方面促进肺泡巨噬细胞自身的MMP9表达和分泌,重构肺部基质环境有利于外来细胞进入,其另一方面通过激活肺泡上皮细胞中的NF-κB信号通路促进炎症因子SAA3转录表达和分泌,进而招募血液中MMP9阳性的髓系细胞至肺部位置,使得肺预转移灶得以形成,两方面共同为肿瘤肺转移奠定环境基础。本项目揭示了肿瘤转移的多种分子机制,为临床高危癌症患者进展治疗提供了新靶点。
国内基金
海外基金